NCT02688426

Brief Summary

The low-level laser therapy (LLLT) has been used in many inflammatory disorders. More recently the LLLT was associated with an improvement in the muscle strength, endurance and functional capacity.But, these effects were described only in health or athletic individuals. In this randomized and controlled clinical trails, the investigators will study the effects of LLLT on functional capacity of the patients with Coronary artery bypass surgery.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
15

participants targeted

Target at below P25 for not_applicable cardiovascular-diseases

Timeline
Completed

Started Mar 2015

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

March 1, 2015

Completed
11 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

February 1, 2016

Completed
17 days until next milestone

First Submitted

Initial submission to the registry

February 18, 2016

Completed
5 days until next milestone

First Posted

Study publicly available on registry

February 23, 2016

Completed
3 months until next milestone

Study Completion

Last participant's last visit for all outcomes

June 1, 2016

Completed
Last Updated

March 23, 2016

Status Verified

March 1, 2016

Enrollment Period

11 months

First QC Date

February 18, 2016

Last Update Submit

March 21, 2016

Conditions

Outcome Measures

Primary Outcomes (1)

  • Six-minute walk test

    up to 2 weeks

Secondary Outcomes (2)

  • Muscle damage

    up to 2 weeks

  • Oxidative stress

    up to 2 weeks

Study Arms (2)

0J LLLT

SHAM COMPARATOR

The sham treatment is performed in the same way as treatment with LBP, however, with the apparatus switched off

Device: Sham Low-Level Laser Therapy (Sham LLLT)Device: 6J Low-Level Laser Therapy (6J LLLT)

6J LLLT

EXPERIMENTAL

The Laser radiation will be made with 6J by spot.

Device: Sham Low-Level Laser Therapy (Sham LLLT)Device: 6J Low-Level Laser Therapy (6J LLLT)

Interventions

perform with the machine off

Also known as: Sham LLLT
0J LLLT6J LLLT

irradiation will be perform with 6J

Also known as: 6J
0J LLLT6J LLLT

Eligibility Criteria

Age40 Years - 75 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Patients in the postoperative period of elective CABG referred for cardiac rehabilitation, which are the 15th and 30th days after surgery without ischemic changes and / or complex arrhythmias on the electrocardiogram, between 40 and 75 years of age who have performed the first surgery.

You may not qualify if:

  • Patients with decompensated heart failure; presence of any comorbidity such as: unstable angina; associated neurological disease; moderate respiratory illness to severe pre-diagnosed by the attending physician; active infectious disease or fever; disabling peripheral vascular disease; unstable ventricular arrhythmias; diabetes mellitus; use of cardiac pacemaker, musculoskeletal disease that limits physical activity, patients with a BMI ≥30.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Rodrigo Della Méa Plentz

Porto Alegre, Rio Grande do Sul, 90050-170, Brazil

RECRUITING

Related Publications (1)

  • Stein C, Fernandes RO, Miozzo AP, Coronel CC, Baroni BM, Bello-Klein A, Plentz RDM. Acute Effects of Low-Level Laser Therapy on Patients' Functional Capacity in the Postoperative Period of Coronary Artery Bypass Graft Surgery: A Randomized, Crossover, Placebo-Controlled Trial. Photomed Laser Surg. 2018 Mar;36(3):122-129. doi: 10.1089/pho.2017.4270. Epub 2018 Feb 21.

MeSH Terms

Conditions

Cardiovascular Diseases

Central Study Contacts

Rodrigo Plentz, PhD

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
DOUBLE
Who Masked
PARTICIPANT, OUTCOMES ASSESSOR
Purpose
TREATMENT
Intervention Model
CROSSOVER
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Clinical Research

Study Record Dates

First Submitted

February 18, 2016

First Posted

February 23, 2016

Study Start

March 1, 2015

Primary Completion

February 1, 2016

Study Completion

June 1, 2016

Last Updated

March 23, 2016

Record last verified: 2016-03

Data Sharing

IPD Sharing
Will not share

Locations